{"id":"W4366987477","doi":"10.51731/cjht.2023.630","title":"Caplacizumab (Cablivi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Clinical trial; Disease; Quality of life (healthcare); Intensive care medicine; Internal medicine; Oncology; Alternative medicine; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001176263,0.0004213063,0.0005265865,0.0008178861,0.0003762925,0.001049928,0.0008866045,0.001193129,0.01420296],"category_scores_gemma":[0.002064231,0.0001334938,0.0006433247,0.0004568212,0.000393864,0.000366308,0.0004526704,0.001396378,0.004726045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00188225,"about_ca_system_score_gemma":0.00202813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006387055,"about_ca_topic_score_gemma":0.01131284,"domain_scores_codex":[0.9993221,0.0001576457,0.00008074137,0.00009991332,0.000239755,0.00009982284],"domain_scores_gemma":[0.9988972,0.0002361431,0.00028257,0.00005977077,0.0003208543,0.0002034414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003680987,0.0002612461,0.002751983,0.002026816,0.0001712475,0.0004569183,0.00004084686,0.0003379507,0.004881292,0.00400845,0.2272551,0.7541272],"study_design_scores_gemma":[0.003370968,0.003334826,0.008346679,0.001376965,0.0002635884,0.00263604,0.0000443264,0.0005879262,0.006338269,0.001106274,0.9725625,0.00003176366],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04448324,0.5072168,0.006641853,0.06822471,0.01226375,0.001553338,0.01032678,0.002509069,0.3467804],"genre_scores_gemma":[0.5804325,0.1381537,0.0214995,0.09177865,0.009435375,0.001423189,0.02107231,0.0002200135,0.1359848],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01420296,"threshold_uncertainty_score":0.0475136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03892056565294667,"score_gpt":0.2855324157177698,"score_spread":0.2466118500648231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}